Is general cancellation of sulfonamides for external treatment justified?;1st die generelle streichung von sulfonamiden in der externen therapie gerechtfertigt?

Hautarzt

Volumn 53, Issue 3, 2002, Pages 225-226

  Heise, Helmut ^a   Box, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; NEOMYCIN; SULFAMERAZINE; SULFONAMIDE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; DRUG LEGISLATION; DRUG MARKETING; DRUG USE; DRUG WITHDRAWAL; HUMAN; NOTE; RISK ASSESSMENT; SKIN ALLERGY; ARTICLE; BACTERIAL SKIN DISEASE; DRUG ERUPTION; MICROBIOLOGY; RISK FACTOR; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS; DRUG ERUPTIONS; HUMANS; RISK FACTORS; SKIN DISEASES, BACTERIAL; SULFONAMIDES;

EID: 0036882429     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-001-0330-8     Document Type: Note

References (6)

1. Aufbereitungsmonographie Sulfamerazin, Kommission B 6, BAnz. Nr. 41 vom 28.2.1990, S 988
2. Höger PH (1998) Topische Antibiotika und Antiseptika. Hautarzt 49:331-347
3. Simon C, Stille W (1993) Lokalantibiotika. In: Simon C, Stille W (Hrsg) Antibiotika-Therapie in Klinik und Praxis, 8. Aufl. Schattauer, Stuttgart, S 207-213
4. McKenna SR, Latenser BA, Jones LM, Parette RR, Sherman HF, Varcelotti JR (1995) Serious silver sulfadiazine and mafenide acetate dermatitis. Burns 21:310-312
5. Yaffee HS, Dressier DP (1969) Topical application of mafenide acetate: Its association with erythema multiforme and cutaneous reactions. Arch Dermatol 100:277-281
6. Fischer H, Reimann H (2000) Sulfonamide nicht auf die Haut. Pharm Ztg 145:2304